Dopamine dosing dilemma.
dc.contributor.author | Sanklecha, M U | en_US |
dc.contributor.author | Raghavan, K | en_US |
dc.contributor.author | Mehta, M N | en_US |
dc.date.accessioned | 1995-05-01 | en_US |
dc.date.accessioned | 2009-05-27T05:15:09Z | |
dc.date.available | 1995-05-01 | en_US |
dc.date.available | 2009-05-27T05:15:09Z | |
dc.date.issued | 1995-05-01 | en_US |
dc.identifier.citation | Sanklecha MU, Raghavan K, Mehta MN. Dopamine dosing dilemma. Indian Pediatrics. 1995 May; 32(5): 607 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/9474 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://indianpediatrics.net | en_US |
dc.subject.mesh | American Heart Association | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Decision Making | en_US |
dc.subject.mesh | Dopamine --administration & dosage | en_US |
dc.subject.mesh | Humans | en_US |
dc.title | Dopamine dosing dilemma. | en_US |
dc.type | Comment | en_US |
dc.type | Letter | en_US |
Files
License bundle
1 - 1 of 1